A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Заболявания:
Hypochondroplasia
Спонсор: BioMarin Pharmaceutical
Налично на:
БГ
Обобщение
This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.
Кой може да участва
Inclusion Criteria:
* Participants must be ≤ 15 years old at the time of signing the informed consent
* Participants must have genetic confirmation of Hypochondroplasia diagnosis
Exclusion Criteria:
* Have a diagnosis of another genetic short stature condition other than Hypochondroplasia or a genetic variant known to cause another genetic syndrome associated with short stature
* Received an investigational product or medical device within 6 months before the Screening visit
Места на провеждане
11
Argentina (1)
Hospital de Pediatria SAMIC Prof. Dr. Juan P Garrahan
Buenos Aires
NOT_YET_RECRUITING
Австралия (1)
Royal Children's Hospital Melbourne
Parkville , Victoria
Бразилия (1)
Hospital de Clinicas de Porto Algre
Porto Alegre , Rio Grande Do Sol
NOT_YET_RECRUITING
Канада (1)
Stollery Children's Hospital
Edmonton , Alberta
Франция (1)
Hospices Civils de Lyon - Hôpital Femme Mère Enfant
Lyon
Германия (1)
Uniklinik Koln
Cologne
Италия (1)
Istituto Giannina Gaslini
Genoa , Liguria
Япония (1)
Kumamoto University Hospital
Kumamoto , Kumamoto
Испания (1)
Hospital Universitario La Paz
Madrid
Великобритания (1)
Great Ormond Street Hospital for Children NHS Foundation Trust